{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:10:06Z","timestamp":1649178606541},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00108-007-1852-7","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T05:29:45Z","timestamp":1176355785000},"page":"476-488","source":"Crossref","is-referenced-by-count":2,"title":["Therapie der ambulant erworbenen Pneumonie"],"prefix":"10.1007","volume":"48","author":[{"given":"T.","family":"Welte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1852_CR1","unstructured":"BQS Qualit\u00e4tsreport 2005. Hrg.: Bundesgesch\u00e4ftsstelle f\u00fcr Qualit\u00e4tssicherung, D\u00fcsseldorf 2006. S.\u00a018\u201327"},{"key":"1852_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jhin.2004.09.037","volume":"60","author":"Engelhart","year":"2005","unstructured":"Engelhart ST, Hanses-Derendorf L, Exner M et al. (2005) Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect 60: 46\u201350","journal-title":"J Hosp Infect"},{"key":"1852_CR3","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","volume":"128","author":"Kollef","year":"2005","unstructured":"Kollef MH, Shorr A, Tabak YP et al. (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 3854\u20133862","journal-title":"Chest"},{"key":"1852_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American","year":"2005","unstructured":"American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388\u2013416","journal-title":"Am J Respir Crit Care Med"},{"key":"1852_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-144-5-200603070-00005","volume":"144","author":"King","year":"2006","unstructured":"King MD, Humphrey BJ, Wang YF et al. (2006) Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144: 309\u2013317","journal-title":"Ann Intern Med"},{"key":"1852_CR6","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","volume":"290","author":"Naimi","year":"2003","unstructured":"Naimi TS, LeDell KH, Como-Sabetti K et al. (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976\u20132984","journal-title":"JAMA"},{"key":"1852_CR7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.1997.03550170070035","volume":"278","author":"Metlay","year":"1997","unstructured":"Metlay JP, Kapoor WN, Fine MJ (1997) Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 278: 1440\u20131445","journal-title":"JAMA"},{"key":"1852_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2796.2006.01657.x","volume":"260","author":"Bauer","year":"2006","unstructured":"Bauer TT, Ewig S, Marre R et al.; The CAPNETZ Study Group (2006) CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260: 93\u2013101","journal-title":"J Intern Med"},{"key":"1852_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/09031936.06.00062505","volume":"27","author":"Capelastegui","year":"2006","unstructured":"Capelastegui A, Espana PP, Quintana JM et al. (2006) Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 27: 151\u2013157","journal-title":"Eur Respir J"},{"key":"1852_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","volume":"363","author":"Christ-Crain","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363: 600\u2013607","journal-title":"Lancet"},{"key":"1852_CR11","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc4955","volume":"10","author":"Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Morgenthaler NG, Stolz D et al. (2006) Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 10: R96","journal-title":"Crit Care"},{"key":"1852_CR12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A. et al. (2007) Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 44: S27\u201372","journal-title":"Clinical Infectious Diseases"},{"key":"1852_CR13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/498119","volume":"41","author":"Bodi","year":"2005","unstructured":"Bodi M, Rodriguez A, Sole-Violan J et al. (2005) Antibiotic prescription for community-acquired pneumonia in the intensive care unit: Impact of adherence to infectious diseases society of America guidelines on survival. Clin Infect Dis 41: 1709\u20131714","journal-title":"Clin Infect Dis"},{"key":"1852_CR14","doi-asserted-by":"crossref","unstructured":"Kohlhammer Y, Raspe H, Marre R et al.; CAPNETZ study group (2006) Antibiotic treatment of community acquired pneumonia varies widely across Germany. J Infect [Epub ahead of print]","DOI":"10.1016\/j.jinf.2006.08.010"},{"key":"1852_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.diagmicrobio.2005.08.012","volume":"54","author":"Deshpande","year":"2001","unstructured":"Deshpande LM, Sader HS, Debbia E et al.; SENTRY Antimicrobial Surveillance Program (2001\u20132004) (2006) Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001\u20132004). Diagn Microbiol Infect Dis 54: 157\u2013164","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1852_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","volume":"37","author":"Yu","year":"2003","unstructured":"Yu VL, Chiou CC, Feldman C et al.; International Pneumococcal Study Group (2003) An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 37: 230\u2013237","journal-title":"Clin Infect Dis"},{"key":"1852_CR17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","volume":"43","author":"Daneman","year":"2006","unstructured":"Daneman N, McGeer A, Green K et al.; Toronto Invasive Bacterial Diseases Network (2006) Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 43: 432\u2013438","journal-title":"Clin Infect Dis"},{"key":"1852_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","volume":"369","author":"Malhotra-Kumar","year":"2007","unstructured":"Malhotra-Kumar S, Lammens C, Coenen S et al. (2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369: 482\u2013490","journal-title":"Lancet"},{"key":"1852_CR19","first-page":"1","volume":"Infect","author":"Schnoor","year":"2007","unstructured":"Schnoor M, Klante T, Beckmann M et al.; The CAPNETZ Study Group (2007) Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect: 1\u20139","journal-title":"Epidemiol"},{"key":"1852_CR20","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/382694","volume":"38","author":"Low","year":"2004","unstructured":"Low DE (2004) Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Clin Infect Dis 38 (Suppl 4): S357\u2013S362","journal-title":"Clin Infect Dis"},{"key":"1852_CR21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhin.2004.12.027","volume":"60","author":"Meyer","year":"2005","unstructured":"Meyer E, Schwab F, Jonas D et al. (2005) Temporal changes in bacterial resistance in German intensive care units, 2001\u20132003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project. J Hosp Infect 60: 348\u2013352","journal-title":"J Hosp Infect"},{"key":"1852_CR22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-2005-870988","volume":"59","author":"H\u00f6ffken","year":"2005","unstructured":"H\u00f6ffken G, Lorenz J, Kern W et al. (2005) S3-Leitlinie zu ambulant erworbener Pneumonie und tiefen Atemwegsinfektionen. Pneumologie 59: 612\u2013664","journal-title":"Pneumologie"},{"key":"1852_CR23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/429242","volume":"40","author":"Vanderkooi","year":"2005","unstructured":"Vanderkooi OG, Low DE, Green K et al. (2005) Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40: 1288\u20131297","journal-title":"Clin Infect Dis"},{"key":"1852_CR24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","volume":"333","author":"Oosterheert","year":"2006","unstructured":"Oosterheert JJ, Bonten MJ, Schneider MM et al. (2006) Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 333: 1193","journal-title":"BMJ"},{"key":"1852_CR25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","volume":"170","author":"Baddour","year":"2004","unstructured":"Baddour LM, Yu VL, Klugman KP et al. (2004) Combination antibiotic therapy lowers mortality among severly ill patients with pneumococcal bacteremia pneumococcal bacteremia. Am J Respir Crit Care Med 170: 440\u2013444","journal-title":"Am J Respir Crit Care Med"},{"key":"1852_CR26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1183\/09031936.06.00126004","volume":"27","author":"Aspa","year":"2006","unstructured":"Aspa J, Rajas O, Rodriguez de Castro F et al.; The Pneumococcal Pneumonia in Spain Study Group (2006) Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 27: 1010\u20131019","journal-title":"Eur Respir J"},{"key":"1852_CR27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","volume":"328","author":"Paul","year":"2004","unstructured":"Paul M, Benuri-Silbiger I, Soares-Weiser K et al. (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328: 668","journal-title":"BMJ"},{"key":"1852_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","volume":"4","author":"Safdar","year":"2004","unstructured":"Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4: 519--527","journal-title":"Lancet Infect Dis"},{"key":"1852_CR29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589\u20131596","journal-title":"Crit Care Med"},{"key":"1852_CR30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","volume":"37","author":"Dunbar","year":"2003","unstructured":"Dunbar LM, Wunderink RG, Habib MP et al. (2003) High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 37: 752--760","journal-title":"Clin Infect Dis"},{"key":"1852_CR31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","volume":"332","author":"el","year":"2006","unstructured":"el Moussaoui R, de Borgie CA, van den Broek P et al. (2006) Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 332: 1355","journal-title":"BMJ"},{"key":"1852_CR32","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/498149","volume":"41","author":"Welte","year":"2005","unstructured":"Welte T, Petermann W, Schurmann D et al.; MOXIRAPID Study Group (2005) Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clin Infect Dis 41: 1697\u20131705","journal-title":"Clin Infect Dis"},{"key":"1852_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R et al. (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174: 84\u201393","journal-title":"Am J Respir Crit Care Med"},{"key":"1852_CR34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A et al. (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171: 242\u2013248","journal-title":"Am J Respir Crit Care Med"},{"key":"1852_CR35","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1378\/chest.118.4.1158","volume":"118","author":"Colice","year":"2000","unstructured":"Colice GL, Curtis A, Deslauriers J et al. (2000) Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 118: 1158\u20131171","journal-title":"Chest"},{"key":"1852_CR36","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","volume":"352","author":"Maskell","year":"2005","unstructured":"Maskell NA, Davies CWH, Nunn AJ et al. (2005) U.K. controlled trial of intrapleural streptokinase for pleural infection. N Eng J Med 352: 865\u2013874","journal-title":"N Eng J Med"},{"key":"1852_CR37","first-page":"817","volume":"174","author":"Maskell","year":"2006","unstructured":"Maskell NA, Batt S, Hedley EL et al. (2006) The bacteriology of pleural infection by genetic and standard methods and its mortality significance. AJRCCM 174: 817\u2013823","journal-title":"AJRCCM"},{"key":"1852_CR38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1378\/chest.108.4.937","volume":"108","author":"Hammond","year":"1995","unstructured":"Hammond JM, Potgieter PD, Hanslo D et al. (1995) The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess. Chest 108: 937\u2013941","journal-title":"Chest"},{"key":"1852_CR39","first-page":"1378","volume":"127","author":"Herth","year":"2005","unstructured":"Herth F, Ernst A, Becker HD (2005) Endoscopic drainage of lung abscesses: technique and outcome. Chest 127: 1378\u20131381","journal-title":"Chest"},{"key":"1852_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1469-0691.2004.00774.x","volume":"10","author":"Allewelt","year":"2004","unstructured":"Allewelt M, Schuler P, Bolcskei PL et al. (2004) Ampicillin + sulbactam vs clindamycin +\/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect 10: 163\u2013170","journal-title":"Clin Microbiol Infect"},{"key":"1852_CR41","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442\u20132449","journal-title":"N Engl J Med"},{"key":"1852_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","volume":"346","author":"Bartlett","year":"2002","unstructured":"Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346: 334\u2013339","journal-title":"N Engl J Med"},{"key":"1852_CR43","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J et al. (2003) Active bacterial core surveillance of the emerging infections program network. Invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348: 1737\u20131746","journal-title":"N Engl J Med"},{"key":"1852_CR44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","volume":"365","author":"Stephens","year":"2005","unstructured":"Stephens DS, Zughaier SM, Whitney CG et al. (2005) Georgia Emerging Infections Program. Incidence of macrolideresistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365: 855\u2013863","journal-title":"Lancet"},{"key":"1852_CR45","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/S0264-410X(02)00112-3","volume":"20","author":"Watson","year":"2002","unstructured":"Watson L, Wilson BJ, Waugh N (2002) Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20: 2166\u20132173","journal-title":"Vaccine"},{"key":"1852_CR46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","volume":"43","author":"Vila-Corcoles","year":"2006","unstructured":"Vila-Corcoles A, Ochoa-Gondar O, Hospital I et al. (2006) Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clinical Infectious Diseases 43: 860\u2013868","journal-title":"Clinical Infectious Diseases"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1852-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1852-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1852-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:11:41Z","timestamp":1558570301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1852-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1852-7","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}